Occult hepatitis B virus infection in patients with chronic liver disease of different etiology in a Brazilian referral center
comparison of two different hepatitis B virus deoxyribonucleic acid amplification protocols: a cross-sectional study
Keywords:
Hepatitis B virus, Liver diseases, Polymerase chain reactionAbstract
BACKGROUND: Occult hepatitis B virus infection (OBI) is defined as the presence of hepatitis B virus (HBV) deoxyribonucleic acid (DNA) in the liver of individuals with undetectable hepatitis B virus surface antigen (HBsAg) in the serum. The actual prevalence of OBI and its clinical relevance are not yet fully understood. OBJECTIVE: To evaluate the prevalence of HBV DNA in liver biopsies of HBsAg-negative patients with chronic liver disease of different etiologies in a referral center in Brazil and compare two different HBV DNA amplification protocols to detect HBV. DESIGN AND SETTING: This cross-sectional observational study was conducted at the Liver Outpatient Clinic, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil, between January 2016 and December 2019. METHODS: HBV DNA was investigated in 104 liver biopsy samples from individuals with chronic liver disease of different etiologies, in whom HBsAg was undetectable in serum by nested-polymerase chain reaction (nested-PCR), using two different protocols. RESULTS: OBI, diagnosed by detecting HBV DNA using both protocols, was detected in 6.7% of the 104 individuals investigated. Both protocols showed a good reliability. CONCLUSION: In addition to the differences in the prevalence of HBV infection in different regions, variations in the polymerase chain reaction technique used for HBV DNA amplification may be responsible for the large variations in the prevalence of OBI identified in different studies. There is a need for better standardization of the diagnostic methods used to diagnose this entity.
Downloads
References
Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479-86. PMID: 12150847; https://doi.org/10.1016/s1473-3099(02)00345-6.
Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol. 2006;101 Suppl 1:S1-6. PMID: 16448446; https://doi.org/10.1111/j.1572-0241.2006.00469.x.
Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4(2):135-84. Erratum in: Lancet Gastroenterol Hepatol. 2019;4(5):e4. PMID: 30647010. https://doi.org/10.1016/S2468-1253(18)30270-X.
Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26(49):6266-73. PMID: 18848855; https://doi.org/10.1016/j.vaccine.2008.09.056.
Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652-7. PMID: 18715666 https://doi.org/10.1016/j.jhep.2008.07.014.
Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58(4):254-7. PMID: 20303674; https://doi.org/10.1016/j.patbio.2010.02.003.
Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25(1):142-63. PMID: 22232374; https://doi.org/10.1128/CMR.00018-11.
Chen J, Liu Y, Zhao J, et al. Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection. PLoS One. 2016;11(5):e0155654. PMID: 27182775; https://doi.org/10.1371/journal.pone.0155654.
Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol. 2016;22(39):8720-34. PMID: 27818588; https://doi.org/10.3748/wjg.v22.i39.8720.
Sadeghi A, Shirvani-Dastgerdi E, Tacke F, et al. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. J Med Virol. 2017;89(2):246-56. PMID: 27381922; https://doi.org/10.1002/jmv.24623.
Roman S. Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America. Ann Hepatol. 2018;17(4):541-3. PMID: 29894289; https://doi.org/10.5604/01.3001.0012.0914.
Patel NH, Meier-Stephenson V, Genetu M, et al. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia. PLoS One. 2020;15(11):e0242577. PMID: 33211768; https://doi.org/10.1371/journal. pone.0242577.
Hao QQ, Wang QH, Xia W, Qian HZ. Circulating miRNA expression profile and bioinformatics analysis in patients with occult hepatitis B virus infection. J Med Virol. 2020;92(2):191-200. PMID: 31513283; https://doi.org/10.1002/jmv.25594.
Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48(1):23-9. PMID: 19919328; https://doi.org/10.1515/CCLM.2010.002.
Ibrahim SAE, Mohamed SB, Kambal S, et al. Molecular Detection of Occult Hepatitis B virus in plasma and urine of renal transplant patients in Khartoum state Sudan. Int J Infect Dis. 2020;97:126-30. PMID: 32497807; https://doi.org/10.1016/j.ijid.2020.05.101.
Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43(2):209-20. PMID: 16440366; https://doi.org/10.1002/hep.21051.
Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136(5):699-712. Erratum in: Br J Haematol. 2007;137(1):81. PMID: 17338776; https://doi.org/10.1111/j.1365-2141.2006.06465.x.
Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341(1):22-6. PMID: 10387938; https://doi.org/10.1056/NEJM199907013410104.
Bréchot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology. 2001;34(1):194-203. PMID: 11431751; https://doi.org/10.1053/jhep.2001.25172.
Chemin I, Trépo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34 Suppl 1:S15-21. PMID: 16461218; https://doi.org/10.1016/s1386-6532(05)80005-8.
Oluyinka OO, Tong HV, Bui Tien S, et al. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS One. 2015;10(7):e0131912. PMID: 26148052; https://doi.org/10.1371/journal.pone.0131912.
Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126(1):102-10. PMID: 14699492; https://doi.org/10.1053/j.gastro.2003.10.048.
Branco F, Mattos AA, Coral GP, et al. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq Gastroenterol. 2007;44(1):58-63. PMID: 17639185; https://doi.org/10.1590/s0004-28032007000100013.
Alencar RS, Gomes MM, Sitnik R, et al. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res. 2008;41(3):235-40. PMID: 18097499; https://doi.org/10.1590/s0100-879x2006005000197.
Albuquerque AC, Coelho MR, Lemos MF, Moreira RC. Occult hepatitis B virus infection in hemodialysis patients in Recife, State of Pernambuco, Brazil. Rev Soc Bras Med Trop. 2012;45(5):558-62. PMID: 23152336; https://doi.org/10.1590/S0037-86822012000500004.
Ferrari TC, Xavier MA, Vidigal PV, et al. Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral center. Braz J Med Biol Res. 2014;47(11):990-4. PMID: 25296362; https://doi.org/10.1590/1414-431X20143782.
Moraes TC, Fiaccadori FS, Souza M, et al. Hepatitis B virus infection among institutionalized mentally ill patients in Brazil. Braz J Infect Dis. 2015;19(6):643-7. PMID: 26361836; https://doi.org/10.1016/j. bjid.2015.07.007.
Chapel F, de Lamballerie X, de Micco C, Lebreuil G, de Micco P. PCR analysis of hepatitis B virus DNA in paraffin-embedded liver tissue from patients with chronic liver disease. Pathol Res Pract. 1995;191(10):961-6. PMID: 8838362; https://doi.org/10.1016/S0344-0338(11)80593-5.
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994 Jul;20(1):15-20. PMID: 8020885; https://doi.org/10.1002/hep.1840200104.30.
Obika M, Shinji T, Fujioka S, et al. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study. Intervirology. 2008;51(1):59-68. PMID: 18349544; https://doi.org/10.1159/000121363.
Georgiadou SP, Zachou K, Liaskos C, et al. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int. 2009;29(3):434-42. PMID: 18694399; https://doi.org/10.1111/j.1478-3231.2008.01851.x.
Wong DK, Huang FY, Lai CL, et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology. 2011;54(3):829-36. PMID: 21809355; https://doi.org/10.1002/hep.24551.
Lok AS, Everhart JE, Di Bisceglie AM, et al. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011;54(2):434-42. PMID: 21374690; https://doi.org/10.1002/hep.24257.
Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol. 2013;59(4):696-700. Erratum in: J Hepatol. 2014;60(1):238. PMID: 23751755; https://doi.org/10.1016/j.jhep.2013.05.043.
Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2(10):1104-8. PMID: 8837608; https://doi.org/10.1038/nm1096-1104.
Abdel-Maksoud NHM, El-Shamy A, Fawzy M, Gomaa HHA, Eltarabilli MMA. Hepatitis B variants among Egyptian patients undergoing hemodialysis. Microbiol Immunol. 2019;63(2):77-84. PMID: 30680771; https://doi.org/10.1111/1348-0421.12670.
Sagnelli E, Imparato M, Coppola N, et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol. 2008;80(9):1547-53. PMID: 18649338; https://doi.org/10.1002/jmv.21239.
Tamori A, Nishiguchi S, Kubo S, et al. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus. Hepatology. 1999;29(5):1429-34. PMID: 10216126; https://doi.org/10.1002/hep.510290520.
Shetty K, Hussain M, Nei L, Reddy KR, Lok AS. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl. 2008;14(4):534-40. Erratum in: Liver Transpl. 2011;17(1):97. PMID: 18324677; https://doi.org/10.1002/lt.21284.
Fang Y, Shang QL, Liu JY, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect. 2009;58(5):383-8. PMID: 19329189; https://doi.org/10.1016/j. jinf.2009.02.013.
Gao XH, Li J, Gong HF, et al. Comparison of Fresh Frozen Tissue With Formalin-Fixed Paraffin-Embedded Tissue for Mutation Analysis Using a Multi-Gene Panel in Patients With Colorectal Cancer. Front Oncol. 2020;10:310. PMID: 32232001; https://doi.org/10.3389/fonc.2020.00310.
Goyal A, Chauhan R. The dynamics of integration, viral suppression and cell-cell transmission in the development of occult Hepatitis B virus infection. J Theor Biol. 2018;455:269-80. PMID: 29969598; https://doi.org/10.1016/j.jtbi.2018.06.020.
Mardian Y, Yano Y, Wasityastuti W, et al. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Virol J.2017;14(1):201. PMID: 29061159; https://doi.org/10.1186/s12985-017-0865-7.
Daef EA, Makhlouf NA, Ahmed EH, et al. Serological and Molecular Diagnosis of Occult Hepatitis B Virus Infection in Hepatitis C Chronic Liver Diseases. Egypt J Immunol. 2017;24(1):37-48. PMID: 29120576.
Cho J, Lee SS, Choi YS, et al. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection. World J Gastroenterol. 2016;22(42):9427-36. PMID: 27895431; https://doi.org/10.3748/wjg.v22.i42.9427.
Rosa AS, Araujo OC, Savassi-Ribas F, et al. Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients. Virus Res. 2017;242:166-72. PMID: 28966070; https://doi.org/10.1016/j.virusres.2017.09.022.
Mondal RK, Khatun M, Banerjee P, et al. Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers. Sci Rep. 2017;7(1):9653. PMID: 28852072; https://doi.org/10.1038/s41598-017-09965-w.
Wong DK, Cheng SCY, Mak LL, et al. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. Clin Gastroenterol Hepatol. 2020;18(2):449-56. PMID: 31252193; https://doi.org/10.1016/j.cgh.2019.06.029.
Mak LY, Wong DK, Pollicino T, et al. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73(4):952-64. PMID: 32504662; https://doi.org/10.1016/j.jhep.2020.05.042.
